Purdue Pharma LP's proposal to resolve the more than 2,000 suits in opioid multidistrict litigation (MDL) has been accepted by the leading plaintiffs' attorneys in these cases, making it the first company to move toward a global resolution of suits alleging manufacturers and distributors fueled the opioid epidemic. However, the company will remain embroiled in litigation by numerous state attorneys general who have rejected its settlement offer.
Purdue, and the Sackler family who owns the company, declined to confirm the details of the proposed settlement but Purdue...
